The clinical significance of HCV core antigen detection during Telaprevir/Peg-Interferon/Ribavirin therapy in patients with HCV 1 genotype infection-Reference-Cited by-同舟云学术

The clinical significance of HCV core antigen detection during Telaprevir/Peg-Interferon/Ribavirin therapy in patients with HCV 1 genotype infection

Published:2015-08 Issue: Volume:69 Page:68-73
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Garbuglia Anna Rosa,Lionetti Raffaella,Lapa Daniele,Taibi Chiara,Visco-Comandini Ubaldo,Montalbano Marzia,D'Offizi Gianpiero,Castiglione Filippo,Capobianchi Maria Rosaria,Paci Paola

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference24 articles.

1. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection;Kanwal;Gastroenterology,2011

2. Liver and intestine transplantation in the United States 1997–2006;Freeman;Am. J. Transplant.,2008

3. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N. Engl. J. Med.,2002

4. Easl clinical practice guidelines: management of hepatitis C virus infection;European Association for the Study of the Liver;J. Hepatol.,2014

5. Telaprevir for previously untreated chronic hepatitis C virus infection;Jacobson;N. Engl. J. Med.,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of HCV Antigen Testing for the Diagnosis and Monitoring of Antiviral Treatment: A Systematic Review and Meta-Analysis;BioMed Research International;2022-01-04

2. Hepatitis C Virus Core Antigen as an Alternative to RNA in the Assessment of Response to Treatment with Direct-acting Oral Antivirals;Hepatitis Monthly;2021-11-16

3. Hepatitis C virus core antigen as a possible alternative for evaluation of treatment effectiveness after treatment with direct-acting antivirals;British Journal of Biomedical Science;2019-09-06

4. HCV core antigen is a useful predictor during pegylated-interferon/ribavirin therapy in patients with hepatitis C virus genotype 1b;Medicine;2019-03

5. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies;The Lancet Gastroenterology & Hepatology;2018-12